Literature DB >> 20589169

Epidermal growth factor receptor gene amplification in atypical adenomatous hyperplasia of the lung.

Maria G McIntire1, Sandro Santagata, Keith Ligon, Lucian R Chirieac.   

Abstract

Atypical adenomatous hyperplasia (AAH) is postulated to be the earliest morphologic precursor lesion in lung carcinogenesis. The epidermal growth factor receptor (EGFR), one of the members of the Erb-2 family of receptors, is commonly expressed in non-small cell lung carcinoma (NSCLC). A subset of the patients with NSCLC has molecular abnormalities in the EGFR gene, including missense mutations and deletions and/or abnormal gene copy numbers, and the relative importance of each of these for patient outcome is an area of great interest. Recent reports show that EGFR mutations are rare or absent in AAH and are rare in bronchioloalveolar carcinoma (BAC). However, the EGFR gene copy number status in AAH is unknown. In this study, we examined the EGFR gene copy number status in lung adenocarcinomas, synchronous AAH, and BAC in surgical pathology resection specimens. EGFR gene copy number was analyzed by chromogenic in situ hybridization (CISH) using formalin fixed paraffin embedded tissue sections and EGFR probes as recommended by the manufacturer. A known positive case of high-grade glioma was used as a positive control. The results indicate that four of eight adenocarcinomas (50%) had more than five EGFR signals per nucleus, suggesting a gain in copy number. Interestingly, in four of nine cases of AAH (44.4%) more than three EGFR signals per nucleus were noted, with scattered cells showing up to 6 signals per nucleus. In addition, in five of 12 cases of BAC (42%), more than three EGFR signals per nucleus were noted. In the remaining cases two to three intranuclear dot-like peroxidase positive signals were present consistent with non-amplification of the gene. Our study reveals an abnormal EGFR gene copy gain in several cases of AAH. In our cohort, the rate of EGFR gene copy abnormalities in AAH appears similar to BAC and lower than in lung adenocarcinomas. These findings suggest that although EGFR gene copy abnormalities may be an early event in lung carcinogenesis, they are associated with tumor progression to invasive cancer and highlight the complexity of tumor morphogenesis.

Entities:  

Keywords:  EGFR; chromogenic in situ hybridization; copy number; lung cancer

Year:  2010        PMID: 20589169      PMCID: PMC2892406     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  32 in total

1.  Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility.

Authors:  Yun Gong; Michael Gilcrease; Nour Sneige
Journal:  Mod Pathol       Date:  2005-08       Impact factor: 7.842

Review 2.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

3.  Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.

Authors:  M Tanner; D Gancberg; A Di Leo; D Larsimont; G Rouas; M J Piccart; J Isola
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.

Authors:  Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F Gazdar; Nobuyoshi Shimizu
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

5.  Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Authors:  Federico Cappuzzo; Fred R Hirsch; Elisa Rossi; Stefania Bartolini; Giovanni L Ceresoli; Lynne Bemis; Jerry Haney; Samir Witta; Kathleen Danenberg; Irene Domenichini; Vienna Ludovini; Elisabetta Magrini; Vanesa Gregorc; Claudio Doglioni; Angelo Sidoni; Maurizio Tonato; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Marileila Varella-Garcia
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506

6.  Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer.

Authors:  Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Wilbur A Franklin; Rafal Dziadziuszko; Nick Thatcher; Alex Chang; Purvish Parikh; José Rodrigues Pereira; Tudor Ciuleanu; Joachim von Pawel; Claire Watkins; Angela Flannery; Gillian Ellison; Emma Donald; Lucy Knight; Dinah Parums; Nicholas Botwood; Brian Holloway
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

7.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

8.  Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.

Authors:  Lynette M Sholl; Beow Y Yeap; A John Iafrate; Alison J Holmes-Tisch; Yi-Ping Chou; Ming-Tsang Wu; Yih-Gang Goan; Li Su; Elisa Benedettini; Jian Yu; Massimo Loda; Pasi A Jänne; David C Christiani; Lucian R Chirieac
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

9.  Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.

Authors:  Yuji Sakuma; Shoichi Matsukuma; Mitsuyo Yoshihara; Yoshiyasu Nakamura; Haruhiko Nakayama; Yoichi Kameda; Eiju Tsuchiya; Yohei Miyagi
Journal:  Mod Pathol       Date:  2007-07-06       Impact factor: 7.842

Review 10.  Early glandular neoplasia of the lung.

Authors:  W H Westra
Journal:  Respir Res       Date:  2000-11-17
View more
  2 in total

Review 1.  Neoplastic cells are a rare component in human glioblastoma microvasculature.

Authors:  Fausto J Rodriguez; Brent A Orr; Keith L Ligon; Charles G Eberhart
Journal:  Oncotarget       Date:  2012-01

2.  Subchronic pulmonary pathology, iron overload, and transcriptional activity after Libby amphibole exposure in rat models of cardiovascular disease.

Authors:  Jonathan H Shannahan; Abraham Nyska; Mark Cesta; Mette C J Schladweiler; Beena D Vallant; William O Ward; Andrew J Ghio; Stephen H Gavett; Urmila P Kodavanti
Journal:  Environ Health Perspect       Date:  2011-10-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.